FUJIFILM Diosynth Begins Work on Bioprocess Innovation Center
PTSM: Pharmaceutical Technology Sourcing and Management
The new facility will feature new research and development capabilities.
FUJIFILM Diosynth announced on Jan. 13, 2015 that the company is opening a new facility in Research Triangle Park, North Carolina. The new location, called the Bioprocess Innovation Center, will offers clients services in process invention and process and product characterization for its clients, according to a press release.
"The construction of this building reflects the continued commitment of our organization to provide our clients with the infrastructure to efficiently and innovatively bring their products to the clinic and beyond for the benefit of their patients," said Steve Bagshaw, CEO, FUJIFILM Diosynth Biotechnologies.
The three-story, 62,000-square-foot facility has an expected completion date in the fourth quarter of 2015.
Source:
FUJIFILM
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
FDA Grants Full Approval for Symptomatic Tenosynovial Giant Cell Tumor Treatment
February 18th 2025Tenosynovial giant cell tumor (TGCT) is rare and non-malignant, forming in or near joints, but which if left untreated can cause damage to joints and surrounding tissue, potentially leading to significant disability.
